Mark Greenwald to Administration, Ophthalmic
This is a "connection" page, showing publications Mark Greenwald has written about Administration, Ophthalmic.
Connection Strength
0.043
-
Refractive outcomes comparing primary laser to primary bevacizumab with delayed laser for type 1 ROP. J AAPOS. 2019 04; 23(2):88.e1-88.e6.
Score: 0.043